peptides and FAQ

You're not in ketosis yet. You're in a transitional glucose-ketone hybrid state where the body hasn't fully shifted fuel preference. Peptides that amplify fat oxidation will act on whatever fuel is available, which in this case includes residual glucose. The effect isn't harmful, but it's not synergistic. Ketone production accelerates after 12–16 hours of fasting or 3–5 days of strict carbohydrate restriction below 20g/day. Waiting until BHB exceeds 1.0 mmol/L ensures the peptide acts primarily on fatty acids, not glucose.

Administer the peptide 30–45 minutes before training, complete the session fasted, then consume your first protein meal immediately post-workout. This captures elevated GH during the training session (which amplifies lipolysis and nutrient partitioning) and times protein intake when both insulin sensitivity and mTOR responsiveness peak. Training itself triggers acute GH elevation. Adding exogenous secretagogues compounds this effect without antagonism since no meal-induced insulin is present.

No. It enhances it. Most time-restricted eating protocols compress meals into 6–8 hour windows, which naturally aligns with pre-lunch or pre-dinner peptide timing. Dose your peptide 60 minutes before breaking your fast with a Mediterranean meal. The fasted state before dosing ensures no competing nutrients interfere with initial absorption, while the subsequent Mediterranean meal captures the receptor upregulation window. Research from the Salk Institute shows that polyphenol intake during the eating window enhances circadian AMPK rhythms, which may further amplify peptide-mediated metabolic effects.

Nausea severity correlates with gastric emptying rate and meal volume. Reduce per-meal protein portion size and increase feeding frequency. Six 25g protein meals cause less GI distress than three 50g meals under GLP-1 receptor activation. Avoid high-fat protein sources (salmon, ribeye, whole eggs) in the 4–6 hours following GLP-1 administration when gastric emptying is slowest. Fat delays emptying further and compounds nausea. If symptoms persist beyond the standard 4–8 week adaptation window, the GLP-1 dose is likely too high for current bodyweight and should be reduced by 25–30%.

Fasted training pairs exceptionally well with the peptides and paleo diet synergy timing protocol if GH secretagogue timing is adjusted. Administer the GH secretagogue 30–45 minutes before training (rather than upon waking), allowing GH levels to peak during the training session when lipolysis demand is highest. The post-workout meal becomes the first protein feeding, consumed immediately after training when insulin sensitivity is elevated and nutrient partitioning favors muscle glycogen replenishment over fat storage. This variation maintains the 90–120 minute gap between peptide dose and first meal while exploiting the metabolic window created by resistance training.

If you administer a peptide and consume protein within 30–60 minutes, insulin from the meal will blunt GH secretion but won't eliminate it entirely. You lose 30–40% of the GH pulse but still activate mTOR from leucine. It's suboptimal but not catastrophic. The greater mistake is skipping the protein meal entirely out of concern about timing. Consistency with leucine intake across the day matters more than perfect timing on any single meal.

Inject after the workout, 30–60 minutes before eating. Resistance training itself triggers acute GH and testosterone release—adding exogenous GH secretagogues during the workout doesn't amplify this meaningfully and may cause lightheadedness or hypoglycemia in a fasted state. Post-workout, endogenous GH is already elevated, somatostatin is still suppressed, and you're 60–90 minutes from your meal—this is the ideal convergence. The peptide-induced GH pulse compounds the exercise-induced pulse, and both peak as you enter the feeding window with depleted glycogen and primed amino acid receptors.

You've neutralized the fat-mobilization effect almost entirely. Insulin elevation above 15 μIU/mL suppresses hormone-sensitive lipase, the enzyme GH activates to release stored fat. The peptide still raises GH levels, but the downstream lipolytic cascade is blocked. If the meal contained carbohydrates, the insulin spike lasts 90–120 minutes. Meaning the peptide's peak activity window occurs while fat oxidation is hormonally shut down. To preserve efficacy, wait until insulin drops below 8 μIU/mL, which typically takes 3–4 hours post-meal in a ketogenic context.

This is one of the highest-synergy windows. Exercise in a fasted ketotic state depletes glycogen, elevates catecholamines (which activate HSL independently), and raises beta-hydroxybutyrate further. Dosing a lean-mass-preserving or recovery peptide within 60 minutes post-training capitalizes on enhanced nutrient partitioning. Amino acids and nutrients are preferentially shuttled to muscle rather than fat because insulin sensitivity is elevated in muscle tissue specifically. The ketotic state also suppresses cortisol-induced muscle breakdown, allowing the peptide to preserve lean mass without requiring carbohydrate intake.

GLP-1 receptor agonists (semaglutide, tirzepatide, Survodutide) benefit most from pre-Mediterranean-meal timing due to receptor density dynamics. Growth hormone secretagogues like MK-677 or CJC-1295 should be dosed 60–90 minutes before meals to avoid insulin interference. Nootropic peptides like Dihexa or Cerebrolysin don't require meal timing but may benefit from polyphenol neuroprotection when dosed alongside olive oil-rich meals.

Dose your peptide 60 minutes before whichever meal contains the highest polyphenol and monounsaturated fat content. Even if it's your only Mediterranean-style meal that day. A single daily receptor window is better than none. The minimum effective Mediterranean meal for this protocol is 20–30ml extra virgin olive oil, 100g legumes or whole grain, and any vegetable. Total prep time under 10 minutes. The receptor upregulation and polyphenol effects occur meal-by-meal, not cumulatively across the day.

Prioritize leaner protein sources (chicken breast, white fish, egg whites) which create less gastric distension per gram of protein compared to fattier cuts. Increase meal frequency to 4–5 smaller feedings rather than 3 larger meals. Spreading 150g daily protein across 5 meals (30g each) is more tolerable under GLP-1 suppression than 3 meals of 50g each. Liquid protein sources (bone broth with collagen peptides, blended egg white smoothies with berries) reduce the mechanical fullness that triggers nausea. If appetite suppression prevents meeting 1.6g/kg minimum, reduce GLP-1 dose rather than accept protein inadequacy. Muscle loss will negate fat loss benefits.

MK-677 (ibutamoren) is an oral ghrelin mimetic with a 24-hour half-life, meaning it doesn't produce discrete GH pulses—it elevates baseline GH and IGF-1 throughout the day. The fasted-state amplification still applies, but the effect is less dramatic than with pulsatile secretagogues like ipamorelin or CJC-1295. For MK-677 users on OMAD, take the dose 60–90 minutes before your meal to align peak plasma concentration with the late fasted period and early feeding window. You won't see the same 300–500% pulse amplitude, but you'll still benefit from reduced somatostatin tone and better insulin-GH sequencing. Our team recommends MK-677 for researchers exploring long-duration GH elevation rather than acute pulsatile protocols.

GLP-1 agonists slow gastric emptying. Adding high-fat meals compounds this effect, which can trigger nausea in sensitive individuals during dose titration. Reduce olive oil to 15ml per meal during weeks 1–4 of peptide therapy, then gradually increase to 30ml as tolerance develops. The polyphenol benefits remain at lower olive oil volumes, though the COMT inhibition effect scales with dose. Alternatively, shift your peptide dose to 90 minutes (instead of 60) before the meal to allow more gastric clearance time.

If combining a GH secretagogue with tissue-repair peptides like Thymalin or Cerebrolysin, administer the GH compound first in a fasted state, then add tissue-specific peptides 30–60 minutes later when GH has already peaked. Repair peptides don't interfere with GH secretion but benefit from the elevated IGF-1 and nutrient transport GH provides. Sequential dosing captures both effects.

You've eliminated most of the synergy. Somatostatin secretion peaks 60–90 minutes post-meal in response to protein and carbohydrate intake, directly inhibiting pituitary GH release even when GHRH analogs or ghrelin mimetics are present. Simultaneously, insulin rises and blocks GH receptor signaling in muscle and adipose tissue—the peptide may still produce a small GH pulse, but downstream lipolysis, IGF-1 synthesis, and protein sparing are suppressed by 40–60%. If timing flexibility is an issue, inject at least 3 hours after eating or switch to the pre-meal window.

Pressure below 2.0 ATA increases dissolved oxygen but remains below the threshold where plasma chemistry meaningfully shifts. University of Pennsylvania data found no measurable peptide bioavailability improvement at 1.5 ATA compared to ambient pressure controls. The effect requires both pressure and oxygen concentration to exceed minimum levels simultaneously. If your facility only offers 1.5 ATA chambers, you'll still receive general HBOT benefits (wound healing, immune modulation) but won't see peptide-specific synergy. Advocating for 2.0+ ATA protocols costs nothing upfront and matters across multi-session treatment plans.

Yes. Extend your pre-session window to 75–90 minutes and consider switching to a sustained-release compound. If you're doing 90-minute reformer sessions, injecting at T-60 means the final third of your session occurs as GH levels begin declining. Injecting at T-90 with a GHRH analog or dual agonist ensures peak concentration occurs during minutes 30–70 of your session. The heaviest working sets. While still maintaining elevated GH throughout cool-down. Pharmacokinetic matching matters: longer sessions require peptides with longer half-lives to maintain hormonal support across the entire training block.

Dose ashwagandha 6+ hours before training or defer it to post-workout recovery. Never within the 2-hour pre-training window if you're injecting peptides pre-workout. The cortisol spike during resistance training is an anabolic signal when paired with GH elevation from peptides like Hexarelin or GHRP-2. Suppressing that spike acutely reduces the training stimulus the peptide is designed to amplify. If you rely on ashwagandha's anxiolytic effects for focus, consider substituting L-theanine or rhodiola during the pre-workout window. Neither compound suppresses cortisol acutely in the way withanolides do.

Subcutaneous and intramuscular peptide administration bypasses first-pass hepatic metabolism, making curcumin's enzyme inhibition irrelevant for that route. However, curcumin's systemic anti-inflammatory effects may still enhance peptide efficacy indirectly by reducing inflammation-driven proteolytic activity in target tissues. For injectable Thymalin, Cerebrolysin, or growth factors, timing precision matters less than formulation purity and reconstitution protocols. Curcumin co-supplementation may support therapeutic outcomes but won't alter peptide pharmacokinetics the way it does with oral administration.